3-12302942-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_138711.6(PPARG):​c.-82-9438A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.24 in 152,130 control chromosomes in the GnomAD database, including 5,241 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.24 ( 5241 hom., cov: 32)

Consequence

PPARG
NM_138711.6 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.312

Publications

13 publications found
Variant links:
Genes affected
PPARG (HGNC:9236): (peroxisome proliferator activated receptor gamma) This gene encodes a member of the peroxisome proliferator-activated receptor (PPAR) subfamily of nuclear receptors. PPARs form heterodimers with retinoid X receptors (RXRs) and these heterodimers regulate transcription of various genes. Three subtypes of PPARs are known: PPAR-alpha, PPAR-delta, and PPAR-gamma. The protein encoded by this gene is PPAR-gamma and is a regulator of adipocyte differentiation. Additionally, PPAR-gamma has been implicated in the pathology of numerous diseases including obesity, diabetes, atherosclerosis and cancer. Alternatively spliced transcript variants that encode different isoforms have been described. [provided by RefSeq, Jul 2008]
PPARG Gene-Disease associations (from GenCC):
  • PPARG-related familial partial lipodystrophy
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • lipodystrophy
    Inheritance: SD Classification: DEFINITIVE Submitted by: ClinGen
  • Berardinelli-Seip congenital lipodystrophy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_138711.6, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.316 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_138711.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PPARG
NM_138711.6
MANE Select
c.-82-9438A>G
intron
N/ANP_619725.3E9PFV2
PPARG
NM_001354666.3
c.-82-9438A>G
intron
N/ANP_001341595.2E9PFV2
PPARG
NM_001354667.3
c.-9+13808A>G
intron
N/ANP_001341596.2E9PFV2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PPARG
ENST00000651735.1
MANE Select
c.-82-9438A>G
intron
N/AENSP00000498313.1E9PFV2
PPARG
ENST00000397010.7
TSL:1
c.-82-9438A>G
intron
N/AENSP00000380205.3E9PFV2
PPARG
ENST00000397015.7
TSL:1
c.-9+14922A>G
intron
N/AENSP00000380210.3E9PFV2

Frequencies

GnomAD3 genomes
AF:
0.241
AC:
36578
AN:
152012
Hom.:
5239
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.113
Gnomad AMI
AF:
0.531
Gnomad AMR
AF:
0.223
Gnomad ASJ
AF:
0.416
Gnomad EAS
AF:
0.0304
Gnomad SAS
AF:
0.142
Gnomad FIN
AF:
0.311
Gnomad MID
AF:
0.344
Gnomad NFE
AF:
0.320
Gnomad OTH
AF:
0.275
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.240
AC:
36582
AN:
152130
Hom.:
5241
Cov.:
32
AF XY:
0.238
AC XY:
17729
AN XY:
74378
show subpopulations
African (AFR)
AF:
0.113
AC:
4692
AN:
41526
American (AMR)
AF:
0.223
AC:
3403
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.416
AC:
1442
AN:
3468
East Asian (EAS)
AF:
0.0307
AC:
159
AN:
5186
South Asian (SAS)
AF:
0.143
AC:
688
AN:
4828
European-Finnish (FIN)
AF:
0.311
AC:
3287
AN:
10570
Middle Eastern (MID)
AF:
0.346
AC:
101
AN:
292
European-Non Finnish (NFE)
AF:
0.320
AC:
21745
AN:
67960
Other (OTH)
AF:
0.275
AC:
581
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1339
2678
4017
5356
6695
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
370
740
1110
1480
1850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.293
Hom.:
17868
Bravo
AF:
0.233
Asia WGS
AF:
0.100
AC:
350
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
1.7
DANN
Benign
0.22
PhyloP100
-0.31
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs7620165;
hg19: chr3-12344441;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.